Published in
Taylor and Francis Group, Expert Review of Molecular Diagnostics, 10(22), p. 937-951, 2022
DOI: 10.1080/14737159.2022.2144235
Links
Tools
Clinical prognostic value of the SMYD2/3 as new epigenetic biomarkers in solid cancer patients: a systematic review and meta-analysis
Journal article published in 2022 by
Mahdieh Razmi,
Ayna Yazdanpanah,
Shahroo Etemad-Moghadam,
Mojgan Alaeddini,
Sabrina Angelini 
,
Leila Eini
,
Leila Eini
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 